Cipher Pharmaceuticals Inc.
TSX:CPH.TO
15.55 (CAD) • At close October 30, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CAD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 21.162 | 20.675 | 21.943 | 21.607 | 22.451 | 22.749 | 40.32 | 40.74 | 34.409 | 8.259 | 25.368 | 8.502 | 3.496 | 5.384 | 3.036 | 1.268 | 0.543 | 0.779 | 0.647 | 25.417 |
| Cost of Revenue
| 4.069 | 3.992 | 3.684 | 3.057 | 2.906 | 2.312 | 1.903 | 4.587 | 2.525 | 1.03 | 0.133 | 1.522 | 0 | 0 | 0 | 0 | 0.173 | 0 | 0 | 0 |
| Gross Profit
| 17.093 | 16.683 | 18.259 | 18.55 | 19.545 | 20.437 | 38.417 | 36.153 | 31.884 | 7.229 | 25.235 | 6.98 | 3.496 | 5.384 | 3.036 | 1.268 | 0.371 | 0.779 | 0.647 | 25.417 |
| Gross Profit Ratio
| 0.808 | 0.807 | 0.832 | 0.859 | 0.871 | 0.898 | 0.953 | 0.887 | 0.927 | 0.875 | 0.995 | 0.821 | 1 | 1 | 1 | 1 | 0.682 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 0.44 | 0.098 | 0.088 | 0.129 | 0.396 | 0.561 | 0.394 | 0.561 | 2.143 | 1.057 | 1.305 | 1.525 | 2.16 | 0.743 | 0.913 | 1.071 | 2.285 | 7.265 | 12.134 | 10.361 |
| General & Administrative Expenses
| 5.393 | 4.4 | 0 | 0 | 0 | 14.741 | 12.782 | 23.739 | 16.594 | 5.678 | 5.836 | 3.545 | 3.12 | 3.894 | 4.061 | 2.929 | 4.893 | 3.444 | 2.696 | 23.302 |
| Selling & Marketing Expenses
| 0 | 1.135 | 0 | 0 | 0 | 0 | 0 | 14.459 | 8.811 | 1.833 | 1.928 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 5.393 | 5.535 | 5.112 | 6.257 | 7.647 | 14.741 | 12.782 | 38.198 | 25.405 | 7.511 | 5.836 | 3.545 | 3.12 | 3.894 | 4.061 | 2.929 | 4.893 | 3.444 | 2.696 | 23.302 |
| Other Expenses
| 1.227 | 0 | 1.25 | 0 | 0 | 0 | 0 | 0 | 4.404 | 0.653 | 1.041 | 1.03 | 0.566 | 0.757 | 0.774 | 0.441 | 0.521 | 0.42 | 0.016 | -2.234 |
| Operating Expenses
| 7.06 | 5.633 | 6.45 | 6.386 | 8.043 | 15.302 | 13.176 | 38.759 | 31.952 | 12.056 | 8.181 | 6.101 | 5.846 | 5.394 | 5.747 | 4.441 | 7.7 | 11.128 | 14.847 | 31.428 |
| Operating Income
| 9.255 | 11.085 | 11.821 | 12.196 | 11.681 | 5.33 | 25.241 | -31.829 | -0.068 | -4.827 | 17.053 | 2.401 | -2.351 | -0.01 | -2.711 | -3.173 | -7.329 | -10.349 | -14.2 | -6.011 |
| Operating Income Ratio
| 0.437 | 0.536 | 0.539 | 0.564 | 0.52 | 0.234 | 0.626 | -0.781 | -0.002 | -0.584 | 0.672 | 0.282 | -0.672 | -0.002 | -0.893 | -2.503 | -13.491 | -13.285 | -21.96 | -0.236 |
| Total Other Income Expenses Net
| 0.778 | 0.394 | -0.762 | -5.66 | -5.971 | -1.3 | -5.684 | -28.503 | 2.374 | 0.465 | 0.238 | 0.156 | 0.087 | 0 | 0 | 0.145 | 0 | 0 | -0.139 | -1.141 |
| Income Before Tax
| 12.681 | 11.479 | 11.059 | 6.536 | 5.71 | 3.123 | 14.265 | -37.657 | -1.147 | -4.825 | 17.291 | 2.557 | -2.263 | 0 | 0 | -3.029 | 0 | -10.349 | -14.34 | -6.488 |
| Income Before Tax Ratio
| 0.599 | 0.555 | 0.504 | 0.302 | 0.254 | 0.137 | 0.354 | -0.924 | -0.033 | -0.584 | 0.682 | 0.301 | -0.648 | 0 | 0 | -2.389 | 0 | -13.285 | -22.176 | -0.255 |
| Income Tax Expense
| -7.702 | -15.157 | 3.301 | 2.15 | 3.071 | 1.922 | 3.518 | 1.492 | -2.916 | -0.284 | -6.157 | -0.156 | -0.087 | -0.066 | -0.118 | -0.519 | -0.821 | 0 | 0.082 | 3.445 |
| Net Income
| 20.383 | 26.636 | 7.758 | 4.549 | 3.242 | 0.543 | 4.403 | -39.149 | 1.769 | -4.825 | 23.448 | 2.557 | -2.263 | 0.056 | -2.593 | -2.654 | -6.508 | -10.349 | -7.325 | -9.932 |
| Net Income Ratio
| 0.963 | 1.288 | 0.354 | 0.211 | 0.144 | 0.024 | 0.109 | -0.961 | 0.051 | -0.584 | 0.924 | 0.301 | -0.648 | 0.01 | -0.854 | -2.093 | -11.98 | -13.285 | -11.328 | -0.391 |
| EPS
| 0.82 | 0.25 | 0.29 | 0.17 | 0.12 | 0.02 | 0.16 | -1.49 | 0.07 | -0.19 | 0.96 | 0.1 | -0.094 | 0.002 | -0.11 | -0.11 | -0.27 | -0.44 | -0.34 | -0.47 |
| EPS Diluted
| 0.8 | 0.25 | 0.29 | 0.17 | 0.12 | 0.02 | 0.16 | -1.45 | 0.07 | -0.19 | 0.91 | 0.1 | -0.094 | 0.002 | -0.11 | -0.11 | -0.27 | -0.44 | -0.34 | -0.47 |
| EBITDA
| 10.482 | 12.074 | 12.522 | 13.401 | 12.868 | 6.158 | 26.216 | 4.348 | 4.768 | -3.527 | 18.109 | 3.452 | -1.748 | 0.747 | -1.938 | -2.732 | -6.808 | -9.93 | -14.184 | -5.202 |
| EBITDA Ratio
| 0.495 | 0.584 | 0.571 | 0.62 | 0.573 | 0.271 | 0.65 | 0.107 | 0.139 | -0.427 | 0.714 | 0.406 | -0.5 | 0.139 | -0.638 | -2.155 | -12.532 | -12.747 | -21.935 | -0.205 |